OPINION REVIEW

1. Mechanisms and consequences of COVID-19 associated liver injury:What can we affirm?

REVIEW

1. Review: Pathogenesis of cholestatic liver diseases
2. Lipidomics in non-alcoholic fatty liver disease
3. Update on diagnosis and management of sepsis in cirrhosis: Current advances

MINIREVIEWS

1. Cell competition in liver carcinogenesis
2. Management of hepatitis C in children and adolescents during COVID-19 pandemic
3. Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update

META-ANALYSIS

1. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis

CASE REPORT

1. Non-islet cell tumor hypoglycemia as an initial presentation of hepatocellular carcinoma coupled with end-stage liver cirrhosis: A case report and review of literature

LETTERS TO THE EDITOR

1. “Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort